Non-Invasive Biomarkers of NASH
The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH). Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022. This browser does not support PDFs. Please download the PDF to view it: Download PDF.